Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease

Journal of the American College of Cardiology

Volumn 31, Issue 6, 1998, Pages 1217-1225

  Mehta, Jawahar L ^a   Saldeen, Tom G P ^b   Rand, Kenneth ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

ANIMALS; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; HLA ANTIGENS; HUMANS; INFECTION; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MYOCARDIAL ISCHEMIA; RISK FACTORS; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 0032080553     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00093-X     Document Type: Review

References (97)

1. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.
2. Janus ED, Postiglione A, Singh RB, Lewis B. The modernization of Asia: implications for coronary heart disease. Circulation 1996;94:2671-3.
3. McGovern PG, Pankow JS, Shahar E, et al., for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.
4. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Effect of risk factors and changes in risk factors on coronary mortality in three cohorts of middle-aged people in eastern Finland. Am J Epidemiol 1995;141:50-60.
5. Tervahauta M, Pekkanen J, Enlund H, Nissinen A. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens 1994;12:1183-9.
6. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90:1-11.
7. Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;74:758.
8. Dahlen GH. Lipoprotein (a) atherosclerosis and thrombosis. Prog Lipid Res 1991;30:189.
9. Steinberg D, Parthasarthy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
10. Hamsten A, de-Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987;2:3-9.
11. Meyers DG. The iron hypothesis - does iron cause atherosclerosis? Clin Cardiol 1996;19:925-9.
12. Cambien F, Polrier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
13. Ohlishi M, Fuji K, Minamino T, et al. A potent genetic risk factor for restenosis. Nature Genet 1993;5:324-5.
14. Dahlen GH, Slunga L, Lindblom B. Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes. Clin Genet 1994;46:46-56.
15. Dahlen GH, Boman J, Birgander LS, Lindblom B. Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis 1995;114:165-74.
16. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
17. Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 1984;53:997-9.
18. Mehta JL, Nichols WW, Mehta P. Neutrophils as potential participants in acute myocardial ischemia. J Am Coll Cardiol 1988;11:1309-16.
19. Mehta JL, Nichols WW, Donnelly WH, et al. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve following coronary occlusion and reperfusion in dog. Circ Res 1989;65:1283-95.
20. Lucchesi BR, Werns SW, Fantone JC. The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol 1989;21:1241-51.
21. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation 1994;90:694-9.
22. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
23. Buja LM. Does atherosclerosis have an infectious etiology? Circulation 1996;94:872-3.
24. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991;43:109-42.
25. Mallory GA, White PO, Salcedo-Salgar J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 patients. Am Heart J 1939;18:647-71.
26. Entman ML, Smith CW. Post-reperfusion inflammation: a model for reaction of injury in cardiovascular disease. Cardiovasc Res 1994;28:1301-11.
27. Nicolini FA, Nichols WW, Saldeen TGP, Mehta JL. Generation of superoxide radicals and release of elastase by neutrophils during thrombolysis [abstract]. J Am Coll Cardiol 1990;15 Suppl A:32A.
28. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation. Circulation 1992;85:230-6.
29. Crawford MH, Grover FL, Kolb WP, et al. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988;78:1449-58.
30. Kulkielka GL, Smith CW, Maning AM, Yonker KA, Michael KH, Entman ML. Induction of interleukin synthesis in the myocardium. Circulation 1995;92:1866-75.
31. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
32. Maroko PR, Carpenter CD, Chiariello M, et al. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 1978;78:1449-58.
33. Chen LY, Nichols WW, Hendricks JB, Yang BC, Mehta JL. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in dogs. Cardiovasc Res 1994;28:1414-22.
34. Simpson PJ, Todd RF, Fantone JC, Mickelson JK, Griffin JD, Lucchesi BR. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo 1, anti CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-9.
35. Li D, Zhao L, Liu M, Zhang J, Mehta JL. Kinetics of TNFα in plasma and the protective effect of monoclonal antibody to TNFα in acute myocardial infarction [abstract]. J Am Coll Cardiol 1998;31:65A.
36. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983;67:1016-23.
37. Mullane KM, Read N, Salmon JA, Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Therap 1984;228:510-22.
38. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-23.
39. Simpson PJ, Mickelson J, Fantone JC, Gallagher KP, Lucchesi BR. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res 1987;60:666-73.
40. Mullane KM. Eicosanoids in Myocardial Ischemia/Reperfusion Injury. 12th ed. Philadelphia: Lippincott-Raven, 1988.
41. Mehta JL, Nichols WW, Saldeen TGP, et al. Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator. J Cardiovasc Pharmacol 1990;16: 112-20.
42. Mehta JL, Nichols WW, Nicolini FA, Hendricks JB, Donnelly WH, Saldeen TGP. Neutrophil elastase inhibitor ICI200,880 protects against attenuation of coronary flow reserve and myocardial dysfunction following temporary coronary artery occlusion in dogs. Cardiovasc Res 1994;28:947-56.
43. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
44. Friedman GD, Klatsky AL, Sieglaub AB. The leukocyte count as a predictor of acute myocardial infarction. N Engl J Med 1974;290:1275-8.
45. Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985;54:700-3.
46. Mehta J, Dinerman J, Mehta P, et al. Neutrophil function in ischemic heart disease. Circulation 1989;79:549-56.
47. Dinerman JL, Mehta JL, Saldeen TGP, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990;15:1559-63.
48. de Servi S, Ricevuti G, Mazzone A, et al. Granulocyte function in coronary artery disease. Am J Cardiol 1991;68:64B-8B.
49. de Servi S, Mazzone A, Ricevuti G, et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990;82:140-6.
50. Neri Serneri GG, Abbate R, Gori AN, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790-7.
51. Mazzone A, de Servi S, Ricevuti G, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-63.
52. Rab ST, Alexander RW, Ansari AA. Evidence for activated circulating macrophages/monocytes in unstable angina. J Am Coll Cardiol 1990;79:549-56.
53. Haught WH, Mansour M, Rothlein R, et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1-6.
54. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of TNF in human atheroma. Am J Cardiol 1989;21:1241-51.
55. Kaartinen M, Penttilä A, Kovanen P. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation 1996;94: 2787-92.
56. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
57. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
58. Ridker PM, Cushman M, Stampfer MJ, Tracy RP. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
59. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley CD. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512-8.
60. Garrett TPJ, Saper MA, Bjorkman PJ, Strombinger JL, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989;342:692-6.
61. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33-93.
62. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol 1992;70:945-9.
63. Frothingham C. The relation between acute infectious diseases and arterial lesions. Arch Intern Med 1911;8:153-62.
64. Ophuls W. Arteriosclerosis and cardiovascular disease: their relation to infectious diseases. JAMA 1921;76:700-1.
65. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978;148:335-40.
66. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989;225:293-6.
67. Mattila KF, Valle MS, Nieminen MS, Valtonen W, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis 1993;103:205-11.
68. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343:435-9.
69. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Beneditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 year old). Proc Natl Acad Sci USA 1995;92:6911-4.
70. Neito FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-7.
71. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn T. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. 1996;64:1614-20.
72. Wyrick PB, Brunridge EA. Growth of Chlamydia psittaci in macrophages. Infect Immun 1978;19:1054-60.
73. Godzik KL, O'Brien ER, Wang S, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-4.
74. Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 1997;45:168-74.
75. Moazed TC, Kuo CG, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Invest Med 1997;45: 168-74.
76. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618.
77. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
78. Saikku P, Mattila K, Nieminen S, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;1:983-5.
79. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984;53:481-2.
80. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
81. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
82. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
83. Saldeen TGP, Ericsson K, Lindquist O, et al. Chlamydia and HLA-DR genotypes in coronary atherosclerosis [abstract]. J Am Coll Cardiol 1998;31: 272A.
84. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
85. Jacob HS, Visser M, Key NS, Goodman JL, Moldow CF, Vercellotti GM. Herpes virus infection of endothelium: new insights into atherosclerosis. Trans Am Clin Climatol Assoc 1992;103:95-104.
86. Span AH, van Dam Mieras MC, Mullers W, Endert J, Muller AD, Braggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991;21:331-8.
87. Hosenpud JD, Chou SW, Wagner CR. Cytomegaloviras-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991;52:896-903.
88. Geist LJ, Dai LY. Cytomegalovirus modulates interleukin-6 gene expression. Transplantation 1996;62:653-8.
89. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994;42:170-4.
90. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993;14 Suppl K:30-8.
91. Dummer S, Lee A, Breinig MK, Kormos R, Ho-M, Griffith B. Investigation of Cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994;44:305-9.
92. Adam E, Melnick JL, Probtsfield JL, et al. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291-3.
93. Rasmussen SJ, Eckmann L, Quayle AI, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997;99:77-87.
94. Sakayama K, Masuno H, Okumura H, Shibata T, Okuda H. Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line. Biochem J 1996;316:813-7.
95. Baumberger C, Ueevitch RJ, Dayer JM. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 1991;59:378-83.
96. Aoki N, Siegried M, Lefer AM. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol 1989;156:H1509-12.
97. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of acute myocardial infarction. Circulation 1997;96:404-7.